ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1904 • 2016 ACR/ARHP Annual Meeting

    Elevated GITRL Is Associated with Multi-Organ Involvement and Increased Disease Activity of Primarty Sjogren’s Syndrome and Promotes Pathogenic Th1/17 Differentiation

    Xiaolin Sun1, Yuzhou Gan Sr.2, Jing He3 and Zhanguo Li4, 1People's hospital,Peking University, Beijing, China, 2Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China, 3Peking Univerisity People's Hospital, Beijing, China, 4Peking University People's Hospital, Beijing, China

    Background/Purpose: Accumulating data showed that Glucocorticoid-induced Tumor Necrosis Factor Receptor Family-related Protein (GITR), with its ligand (GITRL), plays an important role in promoting T-cell-mediated immunity…
  • Abstract Number: 1905 • 2016 ACR/ARHP Annual Meeting

    Therapeutic Targeting of JAK/STAT Pathway Inhibits Follicular Helper T Cell Maturation and Function

    Flora Sagez and Jacques-Eric Gottenberg, Department of Rheumatology, Strasbourg University Hospital, Strasbourg, France

    Background/Purpose:  T follicular helper (Tfh) cells represent a CD4+T cell subset specialized to provide help to B cells and to induce memory B cell and…
  • Abstract Number: 1906 • 2016 ACR/ARHP Annual Meeting

    Impact of Environmental Factors and Inflammation on Alterations of the Total Peripheral T-Cell Compartment in Granulomatosis with Polyangiitis

    Anja Kerstein1, Silke Schueler1, Otávio Cabral-Marques1, Juliane Fazio2, Robert Haesler3, Antje Mueller1, Silke Pitann1, Dietrich Kabelitz2, Frank Moosig4, Sebastian Klapa5, Christian Haas6, Gabriela Riekemasten1, Steffen Wolters1 and Peter Lamprecht1, 1Department of Rheumatology, Vasculitis Center UKSH, University of Lübeck, Luebeck, Germany, 2Institute of Immunology, Christian-Albrechts-University of Kiel, Kiel, Germany, 3Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany, 4Rheumatology Center Schleswig-Holstein Mitte, Neumuenster, Germany, 5Section Maritime Medicine, Institute of Experimental Medicine, Christian-Albrechs-University of Kiel c/o German Naval Medical Institute, Kronshagen, Germany, 6Division of Nephrology, Department of Internal Medicine 1, University of Lübeck, Luebeck, Germany

    Background/Purpose: Autoimmune diseases are driven by a combination of predisposing genetic and environmental factors resulting in self-perpetuating chronic inflammation and tissue damage. In granulomatosis with…
  • Abstract Number: 1907 • 2016 ACR/ARHP Annual Meeting

    T-Bet Regulates Ahr-Mediated Th-17 Differentiation Independently of IFNγ

    Masahiro Yokosawa, Yuya Kondo, Shunta Kaneko, Seiji Segawa, Hiroto Tsuboi, Isao Matsumoto and Takayuki Sumida, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

    Background/Purpose: Our previous reports showed that the development of collagen-induced arthritis was suppressed in T-bet transgenic (T-bet Tg) mice. The regulatory mechanism might relate to…
  • Abstract Number: 1908 • 2016 ACR/ARHP Annual Meeting

    Identification of a Novel Pro-Inflammatory T Cell Epitope from His-tRNA-Synthetase Associated with Interstitial Lung Disease in Anti-Jo-1 Positive Patients

    Angeles Shunashy Galindo-Feria1, Inka Albrecht2, Antonella Notarnicola2, Maryam Dastmalchi2, Anatoly Dubnovitsky3, Tatiana Sandalova3, Genadiy Kozhukh3, Lars Rönnblom4, Adnane Achour5, Vivianne Malmström6 and Ingrid E. Lundberg2, 1Department of Medicine., Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 2Department of Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 3Department of Medicine Solna and Department of Infectious Diseases,, Science for Life Laboratory, Karolinska Institutet and Karolinska University Hospital, Solna, Sweden, 4Uppsala University, Department of Medical Sciences, Rheumatology and Science for Life Laboratory, Uppsala, Sweden, 5Science for Life Laboratory, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, 6Department of Medicine, Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden

    Background/Purpose: Previous studies have demonstrated that CD4+ T cells from peripheral blood of anti-histidyl-tRNA synthetase (anti-His-tRNA) also known as anti-Jo-1 positive patients proliferate in response…
  • Abstract Number: 1909 • 2016 ACR/ARHP Annual Meeting

    The Transcription Factor Fra2 Is Playing a Key Role in Treg Development and Autoimmunity

    Florian Renoux1, Mara Stellato2, Daniela Impellizzieri3, Riyun Huang4, Arun Subramaniam5, Clara Dees6, Jeorg HW Distler6, Gabriela Kania2, Onur Boyman3 and Oliver Distler2, 1Depertment of Rheumatology, University Hospital Zurich, Schlieren, Switzerland, 2Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 3Division of Clinical Immunology, University Hospital Zurich, Zurich, Switzerland, 4Immune Mediated Diseases, Sanofi-Genzyme, Framingham, MA, 5Sanofi-Genzyme, Framingham, MA, 6Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany

    Background/Purpose:   Decreased numbers or altered functions of regulatory T cells (Tregs) have been reported in many inflammatory rheumatic diseases, and Tregs are considered promising…
  • Abstract Number: 1910 • 2016 ACR/ARHP Annual Meeting

    IL-21 Inhibits Treg Differentiation and Function in SLE By Modulating GATA-3 and CTLA-4

    Hiroshi Kato1 and Andras Perl2, 1Division of Rheumatology/Internal Medicine, SUNY Upstate Medical University, Syracuse, NY, 2Department of Medicine, SUNY Upstate Medical University, Syracuse, NY

    Background/Purpose:  Studies indicate quantitative and qualitative Treg insufficiencies underlying the dysregulated immune response in SLE. However, it is unknown what mechanisms drive the Treg dysfunction…
  • Abstract Number: 1911 • 2016 ACR/ARHP Annual Meeting

    Potent and Selective Tyk2 Inhibitor Highly Efficacious in Rodent Models of Inflammatory Bowel Disease and Psoriasis

    Wenyan Miao1, Craig Masse1, Jeremy Greenwood2, Rosana Kapeller1 and William Westlin1, 1Nimbus Therapeutics, Cambridge, MA, 2Schrodinger Inc., New York, NY

    Background/Purpose:  Tyk2 is a member of the JAK family kinases and is a key mediator of IL-12, IL-23, and type I interferon signaling. These cytokines…
  • Abstract Number: 1912 • 2016 ACR/ARHP Annual Meeting

    A New Avenue of Immune Regulation Conferred By Self-Glycerophospholipids Via Mobilization and Migration of Myeloid-Derived Suppressor Cells

    Ramesh Halder1 and Ram R. Singh1,2,3, 1Autoimmunity and Tolerance Laboratory, Department of Medicine/Rheumatology, UCLA, Los Angeles, CA, 2Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, CA, 3Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA

    Background/Purpose: Lipids function as essential components of biological membranes, as signaling molecules, and as energy storage molecules. Glycerol-based phospholipids, called glycerophospholipids (GPL), are the most…
  • Abstract Number: 1913 • 2016 ACR/ARHP Annual Meeting

    B Cell Depletion Therapy Impact CD8 T Cells in ANCA-Associated Vasculitis

    Antoine Néel1,2, Marie Bucchia3, Aurelie Caristan1, Mélanie Néel2, Marie Rimbert4, Christian Agard1, Maryvonne Hourmant5, Gaelle Tilly2, Michelle Yap2, François Perrin1, Pascal Godmer6, Julie Graveleau1, Sophie Brouard2, Celine Bressollette7, Fadi Fakhouri8, Mohamed Hamidou9 and Nicolas Degauque2, 1Internal Medicine Department, Nantes University Hospital, Nantes, France, 2INSERM U1064, Nantes, France, 3Pediatrics, Nantes University Hospital, Nantes, France, 4Immunology Laboratory, Nantes University Hospital, Nantes, France, 5Nephrology, Nantes University Hospital, Nantes, France, 6CH Vannes, Vannes, France, 7Virology Laboratory, Nantes University Hospital, Nantes, France, 8Nephrology Department, Nantes University Hospital, Nantes, France, 9Internal Medicine Department, Internal Medicine Department, Nantes University Hospital, Nantes, France

    Background/Purpose: In anti-neutrophil cytoplasmic antibodies associated vasculitis (AAV), several clues suggest that the efficacy of B cell depletion therapy lies beyond the suppression of ANCA-producing…
  • Abstract Number: 1914 • 2016 ACR/ARHP Annual Meeting

    Immune Recognition of a Novel Citrullinated Epitope of Cartilage Proteoglycan Aggrecan in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis

    Adrienn Markovics1, Timea Ocsko1, Robert S. Katz2, Edit I Buzas3, Tibor T. Glant1 and Katalin Mikecz1, 1Orthopedic Surgery, Rush University Medical Center, Chicago, IL, 2Rush University Medical Center, Chicago, IL, 3Semmelweis University, Budapest, Hungary

    Background/Purpose:  Rheumatoid arthritis (RA) is an autoimmune disease leading to the inflammatory destruction of synovial joints. Anti-citrullinated protein antibodies (ACPA) are frequently detected in the…
  • Abstract Number: 1915 • 2016 ACR/ARHP Annual Meeting

    Partial Elimination of Intestinal Microbiota Dampens T Helper 17 Cell Differentiation and Established Collagen-Induced Arthritis in Mice

    Rebecca Rogier1, Heather Evans-Marin2, Birgitte Walgreen1, Monique M. Helsen1, Liduine van den Bersselaar1, Peter M. van der Kraan1, Fons A.J. van de Loo3, Peter L. van Lent1, Jose U. Scher4, Wim B. van den Berg1, Marije I. Koenders1 and Shahla Abdolahi-Roodsaz1, 1Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands, 2Division of Rheumatology, New York University School of Medicine, New York, NY, 3Rheumatology, Radboud university medical center, Nijmegen, Netherlands, 4New York University School of Medicine, New York, NY

    Background/Purpose: High-throughput sequencing of intestinal microbiota recently revealed that the composition of intestinal microbiota is perturbed in patients with new onset untreated rheumatoid arthritis (RA).…
  • Abstract Number: 1916 • 2016 ACR/ARHP Annual Meeting

    Heightened MAIT Cell Sensitivity to MR1 Ligands Could Impact Control of Dysbiosis in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis

    Diahann Jansen1, Elizabeth Klinken1, Hendrik Nel2, Soi Cheng Law2, Helen Benham3,4,5, Lisa Cummins6, Matthew Brown7, Tony Kenna2, Ligong Liu8, David Fairlie8, Jamie Rossjohn9,10,11, Mark Morrison3, Ranjeny Thomas3, Paraic O Cuiv1, James McCluskey12 and Alexandra Corbett12, 1The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Australia, 2The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia, 3Translational Research Institute, The University of Queensland Diamantina Institute, Woolloongabba, Australia, 4University of Queensland School of Medicine, Brisbane, Australia, 5Rheumatology, Princess Alexandra Hospital, Woolloongabba, Australia, 6Princess Alexandra Hospital, Woolloongabba, Australia, 7Queensland University of Technology, Brisbane, Australia, 8Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia, 9Infection and Immunity Program, Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia, 10Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom, 11Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Australia, 12Department of Microbiology & Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Australia

    Background/Purpose: Mucosal associated invariant T (MAIT) cells are an innate-like lymphocyte population predominant at mucosal sites, which express a semi-invariant T cell receptor restricted to…
  • Abstract Number: 1917 • 2016 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis Cells Produce Extracellular Vesicles That Incorporate PD-1 and microRNAs Targeting the PD-1 Pathway in Surrounding Cells

    Stinne Greisen1,2, Yan Yan3, Aida Hansen1, Morten Venø3, Jens Randel Nyengaard4, Malene Hvid5, Arlene Sharpe6, Jørgen Kjems3 and Bent Deleuran7,8, 1Biomedicine, Aarhus University, Aarhus, Denmark, 2Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 3Interdisciplinari Nanoscience Center (iNANO), Aarhus University, Aarhus, Denmark, 4Clinical Medicine, Electro Microscopy Laboratory, Aarhus University Hospital, Aarhus, Denmark, 5Department of Clinical Medicine, Aarhus University, Aarhus, Denmark, 6Microbiology and Immunobiology, Harvard Medical School, Boston, MA, 7Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 8Department of Biomedicine, Aarhus University, Aarhus, Denmark

    Background/Purpose: Programmed death-1 (PD-1) is a central marker of T cell exhaustion. Exhausted T cells are present in inflammatory conditions, where they fail to eliminate…
  • Abstract Number: 1918 • 2016 ACR/ARHP Annual Meeting

    Characterising the Specificity, Function and Behavior of CD4+ T Cells Initiating Inflammation in a Murine Model of Rheumatoid Arthritis

    Robert Benson1, Catriona Prendergast2, Iain B McInnes2, James Brewer3 and Paul Garside4, 1nstitute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, United Kingdom, 2University of Glasgow, Glasgow, United Kingdom, 3Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom, 4University of Glasgow, Glasgow, Great Britain

    Background/Purpose: CD4+ T cells are important contributors to the pathogenesis of Rheumatoid Arthritis (RA). The presence of activated T cells in the inflamed synovium, strong…
  • « Previous Page
  • 1
  • …
  • 1724
  • 1725
  • 1726
  • 1727
  • 1728
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology